‌

US Patent 7605148 Aqueous oral solution of bisphosphonic acid

Patent 7605148 was granted and assigned to Aurobindo Pharma on October, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

Aurobindo Pharma

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

October 20, 2009

0

Patent Application Number

120827960

Date Filed

April 14, 2008

0

Patent Citations Received

US Patent 11771733 Lisinopril formulations

US Patent 12128083 Lisinopril formulations

0

Patent Primary Examiner

Raymond J. Henley, III

0

Patent abstract

The present invention relates to stable aqueous oral formulation of bisphosphonic acid or its pharmaceutically acceptable salts. More particularly, the present invention relates to stable aqueous oral formulation of alendronate sodium. The present invention also relates to a process for the preparation of stable aqueous oral formulation of alendronate sodium.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7605148 Aqueous oral solution of bisphosphonic acid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.